|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
4D Molecular Therapeutics, Inc.
| | | Phone: | (510) 505-2680 | Year Established: | 2013 | Main Contact: | Theresa Janke, Senior VP, Alliance Management & Business Operations | | Other Contacts: | Leisa Johnson, PhD, VP, R&D Jenny Holt, Project & Alliance Management David Schaffer, PhD, Co-Founder, Acting CSO & Co-Chairman David Kirn, Co-Founder, CEO & Chairman
| | Company Description | 4DMT is focused on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. Their robust discovery platform, termed Therapeutic Vector Evolution, empowers us to create customized gene delivery vehicles to deliver genes to any tissue or organ in the body, by optimal clinical routes of administration and with antibody evasion. These proprietary and targeted products allow us to treat both rare genetic diseases and complex large market diseases. 4D is creating a diverse and deep product pipeline through partnerships, while progressing internal 4D products toward clinical trials in parallel. 4D partners include: Pfizer, Roche, uniQure, AGTC and Benitec. | |
|
|
|
|
|